Risk Adapted Treatment of Myelofibrosis: A Focus on Quality-of-Life (Grand Rounds)
Credit(s): 1.00 (60 min)
Thursday, December 15, 2022 12:30 - 1:30 PM ET
Physicians – AMA PRA Category 1 Credit(s) ™
Physicians/ABIM MOC – ABIM MOC Point(s)
Myelofibrosis is a rare myeloproliferative neoplasm associated with poor outcomes. Because early stages of disease are associated with minimal symptoms, most patients are diagnosed with advanced disease. In these patients, overall survival can be short and the risk of transformation to leukemia is high. To improve patient outcomes, it is important that high-risk patients with advanced disease are identified early and receive appropriate treatment. While historically there have been limited treatment options for advanced myelofibrosis, several novel JAK inhibitors have been approved in the past decade that significantly improve disease symptoms and overall survival, improving patient quality of life. However, use of these agents can be challenging, both in determining the optimal treatment selection, identifying when to switch therapies, and minimizing the impact of disease symptoms and treatment-related adverse events on patient quality-of-life.
This activity, Risk Adapted Treatment of Myelofibrosis: A Focus on Quality-of-Life, will provide hematologists and oncologists with important information on the role of risk stratification in guiding treatment selection, efficacy and safety data for current and emerging myelofibrosis therapies, and strategies for integrating these agents into clinical practice in a way that prolongs survival, minimizes adverse events, and improves patient quality-of-life.
Jointly provided by the Potomac Center for Medical Education and Rockpointe
This program is supported by an educational grant from Bristol Myers Squibb.
Clicking Start Activity indicates that you have reviewed the CME/CE information for this activity
CDK4/6 Inhibitors in the Real World: Evaluating the Evidence in HR-positive/HER2-negative Metastatic Breast Cancer (Grand Rounds)
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.